Pallas Capital Advisors LLC Organogenesis Holdings Inc. Transaction History
Pallas Capital Advisors LLC
- $2.43 Billion
- Q2 2025
A detailed history of Pallas Capital Advisors LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 19,701 shares of ORGO stock, worth $89,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,701
Previous 23,456
16.01%
Holding current value
$89,245
Previous $105,000
31.43%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ORGO
# of Institutions
142Shares Held
67.3MCall Options Held
15.3KPut Options Held
925-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$56.5 Million4.46% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.1MShares$14 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...